Abstracts Archive - Page 1572 of 2425 - ACR Meeting Abstracts

Abstract Number: 2323 • 2016 ACR/ARHP Annual Meeting
Evaluation of Case-Finding Algorithms for Identification of Patients with Dermatomyositis
Kevin Byram¹ and Narender Annapureddy², ¹Internal Medicine, Vanderbilt University, Nashville, TN, ²Rheumatology and Immunology, Vanderbilt University, Nashville, TN
Background/Purpose: In order to enable meaningful clinical care and research, accurate algorithms are needed to identify patients with dermatomyositis (DM). In this study, we aimed…
Abstract Number: 2324 • 2016 ACR/ARHP Annual Meeting
Effects of 12 Weeks Low-Intensity Blood-Flow Restricted Resistance Training on Knee Extensor Strength in Patients with Sporadic Inclusion Body Myositis
Anders Nørkjær Jørgensen¹, Per Aagaard¹, Mette Christiansen¹, Ulrik Frandsen¹ and Louise Pyndt Diederichsen², ¹University of Southern Denmark, Odense, Denmark, ²Rheumatology, Odense University Hospital, Odense, Denmark
Background/Purpose: Sporadic inclusion body myositis (sIBM) represents a progressive inflammatory muscle disease, which causes severe loss in skeletal muscle mass and strength, especially in the…
Abstract Number: 2325 • 2016 ACR/ARHP Annual Meeting
ANTI-Hmgcr Antibodies Demonstrate High Diagnostic VALUE in the Diagnosis of Immune Mediated Necrotizing Myopathy Following Statin Exposure
Ora Shovman¹, Boris Gilburd², Chen Chayat³, Chelsea Bentow⁴, Michael Mahler⁴ and Yehuda Shoenfeld^1,5, ¹Zabludowitz Center for Autoimmune Diseases Sheba Medical Center, Zabludowitz Center for Autoimmune Diseases Sheba Medical Center, 52621, Tel Hashomer, Israel, Ramat Gan, Israel, ²Zabludowitz Center for Autoimmune Diseases Sheba Medical Center, Zabludowitz Center for Autoimmune Diseases Sheba Medical Center, 52621, Tel Hashomer, Israel, Ramat-Gan, Israel, ³Zabludowitz Center for Autoimmune Diseases Sheba Medical Center, 52621, Tel Hashomer, Israel, Ramat Gan, Israel, ⁴Research and Development, Inova Diagnostics, San Diego, CA, ⁵Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, Tel-Aviv, Israel
Background/Purpose: Anti-HMGCR antibodies represent a characteristic serological feature of statin-exposed and statin-unexposed patients with immune mediated necrotizing myopathy (IMNM). We assessed anti-HMGCR antibodies in patients…
Abstract Number: 2326 • 2016 ACR/ARHP Annual Meeting
Intravenous Cyclophosphamide Followed By Oral Immunosuppressive Treatment Versus Rituximab in Inflammatory Myopathy-Related Interstitial Lung Disease
Vincent Langlois¹, Kuberaka Mariampillai², Nicolas Champtiaux³, Marie-Laure Chabi⁴, Yurdagul Uzunhan⁵, Eric Hachulla⁶, Olivier Benveniste⁷ and Baptiste Hervier³, ¹Internal Medicine, University Hospital, Rouen, France, ²Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Department of Internal Medicine and Clinical Immunology, Hospital University Department: inflammation, immunopathology and biotherapy (DHU i2B), Paris, France, Paris, France, ³Internal Medicine, Pitié-Salpêtrière University Hospital, Paris, France, ⁴Radiology department, APHP, Hôpital Pitié Salpêtrière, Paris, France, ⁵Pulmonary diseases department, Avicenne Hospital (AP-HP), Bobigny, France, ⁶Internal Medicine, Lille University Hospital, Lille, France, ⁷Pitié-Salpêtrière University Hospital, Paris, France
Background/Purpose: Interstitial lung disease (ILD) associated with inflammatory myopathy (IM) has a poor prognosis and requires specific treatments. Intravenous Cyclophosphamide (CYC) is one of the…
Abstract Number: 2327 • 2016 ACR/ARHP Annual Meeting
Cardiac Involvement in Inflammatory Myopathies: A Report from the Remicam Registry
rina molina¹, Beatriz E. Joven², Laura Nuño³, Francisco Javier López Longo⁴, MARIA JESUS GARCIA DE YEBENES Y PROUS⁵, VAlentina Maldonado⁶, Carmen Larena⁷, Irene Llorente⁸, Eva Tomero⁹, Carmen Barbadillo¹⁰, Paloma Garcia De La Peña¹¹, Lucía Ruiz Gutiérrez¹², Juan Carlos Lopez-Robledillo¹³, Henry Moruno Cruz¹², Ana Pérez Gómez¹², Tatiana Cobo-Ibáñez¹⁴, Raquel Almodóvar González¹⁵, Leticia Lojo¹⁶ and Patricia Carreira¹⁷, ¹MADRID, Hospital 12 de Octubre, MADRID, Spain, ²Rheumatology, Hospital 12 de Octubre, Madrid, Spain, ³Servicio de Reumatologia, Hospital Universitario La Paz, Madrid, Spain, ⁴Rheumatology, Hospital Gregorio Marañón, Madrid, Spain, ⁵INSTITUTO DE SALUD MUSCULOESQUELÉTICA, MADRID, Spain, ⁶Hospital Ramón y Cajal, Madrid, Spain, ⁷Hospital Gregorio Marañón, Madrid, Spain, ⁸Rheumatology, H.U. La Princesa, Madrid, Spain, ⁹Hospital La Princesa. Madrid., Madrid, Spain, ¹⁰Hospital Universitario Puerta de Hierro, Madrid, Spain, ¹¹Rheumatology, Hospital Madrid Norte Sanchinarro, Madrid, Spain, ¹²University Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology department, Alcalá de Henares, Madrid, Spain, ¹³Hospital Niño Jesus, Madrid, Spain, ¹⁴Hospital Universitario Reina Sofía, Universidad Europea de Madrid, Madrid, Spain, ¹⁵Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, ¹⁶Rheumatology, Hospital Universitario La Paz, Spain, Spain, ¹⁷Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain
Background/Purpose: A multicenter retrospective study from the REMICAM registry was performed. All patients were diagnosed with IM according to Bohan and Peter criteria, followed…
Abstract Number: 2328 • 2016 ACR/ARHP Annual Meeting
Serum Ferritin Levels, Distribution of Ground Glass Opacities and New Development of Lung Infiltration during Therapy Predict Prognosis of Interstitial Lung Disease in Anti-MDA5 Ab Positive Dermatomyositis
Kazuhiro Kurasawa¹, Satoko Arai¹, Yumeko Namiki¹, Ayae Tanaka¹, Ryutaro Yamazaki², Harutsugu Okada¹, Takayoshi Owada¹, Masafumi Arima¹ and Reika Maezawa¹, ¹Rheumatology, Dokkyo Medical University, Mibu, Tochigi, Japan, ²Rheumatology, Dokkyo Medical University, Mibu, tochigi, Japan
Background/Purpose: Anti-MDA5 Ab positive dermatomyositis (DM) is a unique subset of inflammatory myopathy characterized by non- or mild muscle weakness, skin manifestation such as…
Abstract Number: 2329 • 2016 ACR/ARHP Annual Meeting
Intravenous Immunoglobulins in the Treatment of Idiophatic Inflammatory Myopathies: Where Do We Stand?
Simone Barsotti^1,2, Elisa Cioffi¹, Alessandra Tripoli¹, Emanuele Calabresi¹, Antonio Gaetano Tavoni³, Anna d'Ascanio¹, Rossella Neri⁴ and Marta Mosca¹, ¹Rheumatology Unit, University of Pisa, Pisa, Italy, ²University of Siena, Department of Medical Biotechnologies, Siena, Italy, ³Immunoallergology Unit, University of Pisa, Pisa, Italy, ⁴Rheumatology Unit, University of Pisa, PISA, Italy
Background/Purpose: several data are available about the use of IvIg in the treatment of idiopathic inflammatory myopathies (IIM), but the results derive from small cohorts.…
Abstract Number: 2330 • 2016 ACR/ARHP Annual Meeting
Ultrasound Imaging in Inclusion Body Myositis
Jemima Albayda¹, Julie J. Paik¹, Clifton Bingham III², Lisa Christopher-Stine³, Tae Chung⁴, Philippe Burlina⁵ and Seth Billings⁵, ¹Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Divisions of Rheumatology and Allergy, Department of Medicine, Johns Hopkins University, Johns Hopkins University, Baltimore, MD, ³Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Johns Hopkins University, Baltimore, MD, ⁵Johns Hopkins University Applied Physics Lab, Laurel, MD
Background/Purpose: Inclusion body myositis (IBM) is the most common idiopathic inflammatory myopathy in patients over the age of 50. For atypical or early cases where…
Abstract Number: 2331 • 2016 ACR/ARHP Annual Meeting
Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis
Jasvinder A. Singh¹, Bradley Young², Shawna Watson³, jorge perez², Gerald McGwin² and Brent Ponce², ¹Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL, ³university of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The purpose of this study was to analyze time-trends in various types of total joint arthroplasty (TJA) and assess if the proportion of the…
Abstract Number: 2332 • 2016 ACR/ARHP Annual Meeting
Midterm Outcome of Modular Metal-on-Metal Total Hip Arthroplasty
Hiroki Wakabayashi¹, Masahiro Hasegawa², Toshio Yamaguchi³, Yohei Naito⁴ and Akihiro Sudo⁵, ¹Department of Orthopaedic Surgery, Graduate School of Medicine, Mie University, Tsu City, Japan, ²Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu City, Mie, Japan, ³Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Japan, ⁴Department of Orthopaedic Surgery, Graduate School of Medicine, Mie University, Tsu City, Mie, Japan, ⁵Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu City, Japan
Background/Purpose: Wear, osteolysis, and late aseptic loosening associated with ultrahigh-molecular-weight polyethylene components used in total hip arthroplasties (THA) have led to increased interest in metal-on-metal…
Abstract Number: 2333 • 2016 ACR/ARHP Annual Meeting
Comparison of Clinical Outcomes of Total Ankle Arthroplasty Between Biologics and NON-Biologics Treatment Groups in Patients with Rheumatoid Arthritis
Makoto Hirao¹, Kosuke Ebina², Takaaki Noguchi³, Hideki Tsuboi⁴, Jun Hashimoto⁵ and Hideki Yoshikawa⁶, ¹Orthopaedic Surgery, Osaka University, Graduate School of Medicine, Suita, Japan, ²Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan, ³Orthopaedic Surgery, Osaka University, Graduate School of Medicine, Osaka, Japan, ⁴Osaka Rosai Hospital, Sakai, Japan, ⁵Dept of Rheumatology, Osaka-Minami Medical Center, Kawachinagano City, Japan, ⁶Department of Orthopedics, Osaka University Graduate School of Medicine, Suita Osaka, Japan
Background/Purpose: In progress of medical treatment against rheumatoid arthritis (RA) disease activity using methotrexate (MTX) and/or biologics, we often see cases that require surgical intervention…
Abstract Number: 2334 • 2016 ACR/ARHP Annual Meeting
Ultrasound-Guided Facet Joint Injections through a Longitudinal Approach
Christelle Darrieutort-Laffite, Antoine Colombey, Joelle Glemarec, Yves Maugars and Benoit Le Goff, Rheumatology, Nantes University Hospital, Nantes, France
Background/Purpose: Facet joint-mediated pain has been identified as a common cause of lumbar pain. Steroid injections are currently made to treat them, usually performed under…
Abstract Number: 2335 • 2016 ACR/ARHP Annual Meeting
Recent Changes of Radiological Findings and Patients’ Background of Rheumatoid Hip and Knee
Yuichi Mochida¹, Katsushi Ishii², Hiroyuki Miyamae², Naoto Mitsugi³ and Tomoyuki Saito⁴, ¹Center for rheumatic diseases, Yokohama City University Medical Center, Yokohama, Japan, ²Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan, ³Dept. of Orthopaedic surgery,, Yokohama City University Medical Center, Yokohama, Japan, ⁴Dept. of Orthopaedic surgery, Yokohama City University School of Medicine, Yokohama, Japan
Background/Purpose: Treatment of rheumatoid arthritis (RA) has been dramatically changed by methotrexate (MTX) and biologics. According to introduction of these effective drugs for the control…
Abstract Number: 2336 • 2016 ACR/ARHP Annual Meeting
Splinting for Trigger Finger. Short Term Effects
V. De Cillis¹, A. Perez Davila², A. Bohr³ and E. Scheines⁴, ¹Occupational Therapy, Hospital de Rehabilitacion Manuel Rocca, Buenos Aires, Argentina, ²Rheumatology, Hospital de Rehabilitación Manuel Rocca, Ciudad Autonoma de Buenos Aires, Argentina, ³Rheumatology, Hospital Manuel Rocca, Ciudad Autonoma de Buenos Aires, Argentina, ⁴Rheumatology, Hospital Manuel Rocca, Buenos Aires, Argentina
Background/Purpose: Inflammatory processes of flexor tendons of fingers can produce pain and less (impaired) functionality. Trigger finger (stenosing tenosynovitis) is frequently seen in clinical practice.…
Abstract Number: 2337 • 2016 ACR/ARHP Annual Meeting
Sleep Quality, Disturbances and Physical Activity: A Nationwide Survey Among Health Professionals on Their Engagement with Irish People Who Have Rheumatic Disease
Sean McKenna¹, Alan Donnelly², Sandy Fraser³ and Norelee Kennedy¹, ¹Department of Clinical Therapies, University of Limerick, Ireland, Limerick, Ireland, ²Department of Physical Education and Sports Sciences, University of Limerick, Ireland, Limerick, Ireland, ³Department of Rheumatology, University Hospitals Limerick, Ireland, Limerick, Ireland
Background/Purpose: Sleep disturbance is common in people who have inflammatory arthritis and can contribute to disability, symptomatology, and use of increased healthcare. Disturbed sleep is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].